Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WANETAM is a leading research consortium dedicated to strengthening the capacity for clinical trials and health research across West Africa. Established with support from the European & Developing Countries Clinical Trials Partnership (EDCTP), the network focuses on major infectious diseases including tuberculosis, HIV/AIDS, and malaria, as well as emerging pathogens and neglected tropical diseases. WANETAM facilitates collaborative research, provides training for African scientists, and harmonizes laboratory and clinical practices across its member institutions. By fostering regional cooperation, the network aims to accelerate the development of new tools, diagnostics, and treatments tailored to the specific health needs of West African populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WANETAM.